Atkinson Edward Morrow III - Insider Non-Derivative Transactions at VERTEX PHARMACEUTICALS INC / MA (VRTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 17, 2025, Atkinson Edward Morrow III's relationship to VERTEX PHARMACEUTICALS INC / MA (VRTX) is Officer (EVP, Chief Technical Ops. Off.), and currently has 16,852 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other VRTX insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
Atkinson Edward Morrow III - Insider Non-Derivative Transactions of VRTX Common Stock
Atkinson Edward Morrow III - Insider Non-Derivative Transactions at VRTX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Nov 18, 2025 Sell -- (Common Stock) 2500 434.58 16852
Feb 28, 2025 Sell -- (Common Stock) 2650 475.34 19352
Feb 27, 2025 F -- (Common Stock) 2482 479.61 22002
Feb 26, 2025 Sell -- (Common Stock) 1767 480.95 24484
Feb 25, 2025 F -- (Common Stock) 1656 483.28 26251
Feb 15, 2025 F -- (Common Stock) 1529 463.46 27907
Feb 13, 2025 Acquisition -- (Common Stock) 6211 0 29436
Feb 12, 2025 Sell -- (Common Stock) 1747 459.83 23225
Feb 11, 2025 F -- (Common Stock) 876 467.98 24972
Feb 5, 2025 Acquisition -- (Common Stock) 5132 0 21104
Feb 5, 2025 Acquisition -- (Common Stock) 4744 0 25848
Jun 13, 2024 Sell -- (Common Stock) 7288 478 15972
Jun 12, 2024 F -- (Common Stock) 6824 481.96 23260
May 15, 2024 Acquisition -- (Common Stock) 14112 0 30084
Feb 27, 2024 Sell -- (Common Stock) 883 425.7 15972
Feb 24, 2024 F -- (Common Stock) 1654 431.79 16855
Feb 22, 2024 Sell -- (Common Stock) 1201 421.77 18509
Feb 21, 2024 Sell -- (Common Stock) 801 420.79 19710
Feb 21, 2024 F -- (Common Stock) 1125 420.58 20511
Feb 17, 2024 F -- (Common Stock) 1501 424.01 21636
Feb 13, 2024 Sell -- (Common Stock) 913 420.24 23137
Feb 10, 2024 F -- (Common Stock) 832 422.74 24050
Feb 8, 2024 Acquisition -- (Common Stock) 4743 0 24882
Feb 7, 2024 Acquisition -- (Common Stock) 2326 0 16205
Feb 7, 2024 Acquisition -- (Common Stock) 3934 0 20139